Cerecor Archives · BioBuzz

Loading …

2020’s Top 10 Most Read News Stories from the BioHealth Capital Region

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2020/12/2020-Top-Read-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/12/2020-Top-Read-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2020/12/2020-Top-Read-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2020/12/2020-Top-Read-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2020/12/2020-Top-Read-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2020/12/2020-Top-Read-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/12/2020-Top-Read-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2020/12/2020-Top-Read-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : December 24, 2020December 22, 2020 Published by : Steven Surdez

2020 found the United States embroiled in a chaotic political environment, reckoning with social unrest and racial injustice, and voting in one of the most consequential presidential elections in the country’s history.

Five Biotechs Poised to Advance Their Rare Disease Programs in 2020

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2020/01/Rare-Disease-RD-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : January 28, 2020January 28, 2020 Published by : Steven Surdez

Five Biotechs Poised to Advance Their Rare Disease Programs in 2020 On the cusp of rare disease month, we’re checking in with Maryland biotech companies at the forefront of rare [….]

Cerecor Announces $43 Million Deal with AYTU BioScience to Sell Pediatric Portfolio and Advance Towards NDA

<img width="300" height="212" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/10/cerecor-300x212.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/10/cerecor-120x86.jpg 120w" data-src="https://biobuzz.io/wp-content/uploads/2019/10/cerecor-300x212.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="212" src="https://biobuzz.io/wp-content/uploads/2019/10/cerecor-300x212.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/10/cerecor-300x212.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/10/cerecor-120x86.jpg 120w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 14, 2019September 26, 2020 Published by : Chris Frew

Cerecor Announces $43 Million Deal with AYTU BioScience to Sell Pediatric Portfolio and Advance Towards NDA

Why Developing Cures for Rare Disease Isn’t So Rare Anymore

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/09/Rare-Disease-Featured-Article-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : September 3, 2019September 5, 2019 Published by : Steven Surdez

Why Developing Cures for Rare Disease Isn’t So Rare Anymore These Six Maryland Biotech Companies Are Seeing Success in Targeting Rare Diseases September 3, 2019 Groundbreaking technology and scientific advancements, [….]